• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用尿液生物标志物区分感觉性膀胱障碍女性的膀胱功能障碍。

Using Urine Biomarkers to Differentiate Bladder Dysfunctions in Women with Sensory Bladder Disorders.

机构信息

Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.

出版信息

Int J Mol Sci. 2024 Aug 29;25(17):9359. doi: 10.3390/ijms25179359.

DOI:10.3390/ijms25179359
PMID:39273307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11395209/
Abstract

Sensory bladder disorders encompass several distinct conditions with overlapping symptoms, which pose diagnostic challenges. This study aimed to evaluate urine biomarkers for differentiating between various sensory bladder disorders, including non-Hunner's interstitial cystitis (NHIC), detrusor overactivity (DO), hypersensitive bladder (HSB), and urodynamically normal women. A retrospective analysis of 191 women who underwent a videourodynamic study (VUDS) was conducted, with some also receiving cystoscopic hydrodistention to confirm the presence of NHIC. Participants were categorized into four groups: DO (n = 51), HSB (n = 29), NHIC (n = 81), and normal controls (n = 30). The urine levels of inflammatory and oxidative stress biomarkers were measured. The DO patients exhibited elevated IP-10 levels, while the HSB patients had decreased TAC and 8-OHdG levels. The NHIC patients showed lower IL-2 and higher TNF-α levels. A TNF-α ≥ 1.05 effectively identified NHIC, with an AUROC of 0.889, a sensitivity of 98.8%, and a specificity of 81.3%. An IP-10 ≥ 6.31 differentiated DO with an AUROC of 0.695, a sensitivity of 56.8%, and a specificity of 72.3%. An 8-OHdG ≤ 14.705 and a TAC ≤ 528.7 identified HSB with AUROCs of 0.754 and 0.844, respectively. The combination of 8-OHdG and TAC provided an AUROC of 0.853 for HSB. These findings suggest that TNF-α, IP-10, TAC, 8-OHdG, and IL-2 are promising non-invasive biomarkers for distinguishing between these conditions, which may improve diagnosis and management.

摘要

感觉性膀胱障碍包括几种具有重叠症状的不同疾病,这给诊断带来了挑战。本研究旨在评估尿液生物标志物,以区分各种感觉性膀胱障碍,包括非 Hunner 间质性膀胱炎 (NHIC)、逼尿肌过度活动症 (DO)、高敏感膀胱 (HSB) 和尿动力学正常的女性。对 191 名接受视频尿动力学研究 (VUDS) 的女性进行了回顾性分析,其中一些还接受了膀胱镜下注水扩张以确认 NHIC 的存在。参与者被分为四组:DO (n = 51)、HSB (n = 29)、NHIC (n = 81) 和正常对照组 (n = 30)。测量了炎症和氧化应激生物标志物的尿液水平。DO 患者的 IP-10 水平升高,而 HSB 患者的 TAC 和 8-OHdG 水平降低。NHIC 患者的 IL-2 水平较低,TNF-α 水平较高。TNF-α ≥ 1.05 可有效识别 NHIC,AUROC 为 0.889,灵敏度为 98.8%,特异性为 81.3%。IP-10 ≥ 6.31 可区分 DO,AUROC 为 0.695,灵敏度为 56.8%,特异性为 72.3%。8-OHdG ≤ 14.705 和 TAC ≤ 528.7 可分别识别 HSB,AUROC 分别为 0.754 和 0.844。8-OHdG 和 TAC 的组合对 HSB 的 AUROC 为 0.853。这些发现表明,TNF-α、IP-10、TAC、8-OHdG 和 IL-2 是区分这些疾病的有前途的非侵入性生物标志物,可能改善诊断和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/f9995f0f14d6/ijms-25-09359-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/ef0539ccf960/ijms-25-09359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/fa8e699f59a8/ijms-25-09359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/f9995f0f14d6/ijms-25-09359-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/ef0539ccf960/ijms-25-09359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/fa8e699f59a8/ijms-25-09359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19a1/11395209/f9995f0f14d6/ijms-25-09359-g003.jpg

相似文献

1
Using Urine Biomarkers to Differentiate Bladder Dysfunctions in Women with Sensory Bladder Disorders.利用尿液生物标志物区分感觉性膀胱障碍女性的膀胱功能障碍。
Int J Mol Sci. 2024 Aug 29;25(17):9359. doi: 10.3390/ijms25179359.
2
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.尿生物标志物在评估间质性膀胱炎/膀胱疼痛综合征患者膀胱状况和组织病理学中的作用。
Int J Mol Sci. 2022 Oct 10;23(19):12044. doi: 10.3390/ijms231912044.
3
Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.尿生物标志物在鉴别间质性膀胱炎/膀胱疼痛综合征与男性下尿路功能障碍中的应用
Int J Mol Sci. 2023 Jul 27;24(15):12055. doi: 10.3390/ijms241512055.
4
Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.尿氧化应激生物标志物水平可能有助于识别患有尿频尿急综合征的女性的功能性膀胱疾病。
J Clin Med. 2023 Mar 17;12(6):2336. doi: 10.3390/jcm12062336.
5
Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.尿 CXCL10 作为预测 Hunner 型间质性膀胱炎的生物标志物的诊断价值。
Neurourol Urodyn. 2018 Mar;37(3):1113-1119. doi: 10.1002/nau.23431. Epub 2017 Oct 19.
6
Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology.间质性膀胱炎/膀胱疼痛综合征的尿动力学特征——膀胱出口功能障碍在发病机制中的作用。
Neurourol Urodyn. 2018 Aug;37(6):1971-1977. doi: 10.1002/nau.23542. Epub 2018 Mar 5.
7
Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.间质性膀胱炎和膀胱过度活动症患者尿液炎症标志物的比较。
Int Urogynecol J. 2018 Jul;29(7):961-966. doi: 10.1007/s00192-017-3547-5. Epub 2018 Jan 25.
8
Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.尿液生物标志物可能是下尿路功能障碍鉴别诊断的一种有用工具。
Tzu Chi Med J. 2023 Dec 13;36(2):110-119. doi: 10.4103/tcmj.tcmj_221_23. eCollection 2024 Apr-Jun.
9
Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study.尿生物标志物在鉴别伴有膀胱过度活动症的女性排尿功能障碍中的性能:一项前瞻性初步研究。
Int Urol Nephrol. 2022 Oct;54(10):2497-2502. doi: 10.1007/s11255-022-03265-7. Epub 2022 Jul 20.
10
Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome.通过尿频-尿急综合征女性患者的尿生物标志物鉴别不同的膀胱及膀胱出口功能障碍
Biomedicines. 2023 Feb 23;11(3):673. doi: 10.3390/biomedicines11030673.

引用本文的文献

1
Exploring promising biomarkers based on pathogenic mechanisms in interstitial cystitis/bladder pain syndrome.基于间质性膀胱炎/膀胱疼痛综合征发病机制探索有前景的生物标志物。
Nat Rev Urol. 2025 Sep 11. doi: 10.1038/s41585-025-01078-8.
2
Integrating biomarker clustering for improved diagnosis of interstitial cystitis/bladder pain syndrome: a review.整合生物标志物聚类以改善间质性膀胱炎/膀胱疼痛综合征的诊断:综述
Int Urol Nephrol. 2025 Mar 15. doi: 10.1007/s11255-025-04452-y.
3
Higher skin sympathetic nerve activity as a potential predictor of overactive bladder in females refractory to oral monotherapy.

本文引用的文献

1
Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.膀胱疼痛综合征/间质性膀胱炎患者的潜在尿液和血清生物标志物。
Arch Esp Urol. 2024 May;77(4):353-358. doi: 10.56434/j.arch.esp.urol.20247704.48.
2
Age-specific prevalence, clinical and urodynamic findings of detrusor underactivity and bladder outlet obstruction in female voiding dysfunction.女性排尿功能障碍中逼尿肌活动低下和膀胱出口梗阻的年龄特异性患病率、临床和尿动力学表现。
Int J Gynaecol Obstet. 2024 Nov;167(2):797-803. doi: 10.1002/ijgo.15705. Epub 2024 May 27.
3
Evaluating symptom severity and urinary cytokine levels in interstitial cystitis/bladder pain syndrome patients, with and without Hunner's lesions.
皮肤交感神经活动增高可能是女性口服单一疗法抵抗性膀胱过度活动症的潜在预测指标。
Kaohsiung J Med Sci. 2024 Nov;40(11):1020-1028. doi: 10.1002/kjm2.12899. Epub 2024 Oct 9.
评估间质性膀胱炎/膀胱疼痛综合征患者(有或无Hunner溃疡)的症状严重程度和尿液细胞因子水平。
Am J Clin Exp Urol. 2024 Apr 15;12(2):110-118. doi: 10.62347/BLED2401. eCollection 2024.
4
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.使用晨尿样本对膀胱癌患者进行微生物组分析。
Eur Urol Open Sci. 2023 Dec 19;59:18-26. doi: 10.1016/j.euros.2023.11.003. eCollection 2024 Jan.
5
How does the lower urinary tract contribute to bladder sensation? ICI-RS 2023.下尿路如何影响膀胱感觉?ICI-RS 2023。
Neurourol Urodyn. 2024 Aug;43(6):1293-1302. doi: 10.1002/nau.25316. Epub 2023 Oct 30.
6
Role of cystoscopy as primary initial investigation in interstitial cystitis/bladder pain syndrome.膀胱镜检查在间质性膀胱炎/膀胱疼痛综合征中的初步初始检查作用。
Urologia. 2024 Feb;91(1):189-193. doi: 10.1177/03915603231203431. Epub 2023 Sep 29.
7
Thai traditional massage modulates urinary MCP-1 and relevant inflammatory biomarkers in lower urinary tract symptom patients.泰国传统按摩可调节下尿路症状患者尿液中的单核细胞趋化蛋白-1及相关炎症生物标志物。
J Tradit Complement Med. 2023 Jun 12;13(5):521-529. doi: 10.1016/j.jtcme.2023.06.001. eCollection 2023 Sep.
8
Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.尿生物标志物在鉴别间质性膀胱炎/膀胱疼痛综合征与男性下尿路功能障碍中的应用
Int J Mol Sci. 2023 Jul 27;24(15):12055. doi: 10.3390/ijms241512055.
9
Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.尿氧化应激生物标志物水平可能有助于识别患有尿频尿急综合征的女性的功能性膀胱疾病。
J Clin Med. 2023 Mar 17;12(6):2336. doi: 10.3390/jcm12062336.
10
Skin sympathetic nerve activity as a potential biomarker for overactive bladder.皮肤交感神经活动作为一种潜在的膀胱过度活动症生物标志物。
World J Urol. 2023 May;41(5):1373-1379. doi: 10.1007/s00345-023-04376-1. Epub 2023 Mar 27.